Poor quality medicines putting the lives of pregnant women at risk
Independent evaluation of global COVID-19 response announced
#EndTB Webinar: From Policy to Practice: Rolling out new WHO guidelines on rapid diagnostics and drug-resistant TB treatment
Addressing the crisis in antibiotic development
WHO experts to travel to China
Update from WHO and Pew Charitable Trusts: urgent action needed to accelerate antibiotic development
WHO launches iSupport Lite
WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls
Complementarity of governance structures for antimicrobial resistance: The Independent Panel for Evidence, The Global Leaders Group and the Partnership Platform
WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19
